Newsletter | April 17, 2025

04.17.25 -- Struggling With CDMO Fit, Capacity, Or Delays? Let's Solve These Challenges Together!

Your CDMO Capacity Search Starts Here.

It's more than a slogan. At Outsourced Pharma, we understand the incredible amount of time and effort it takes to find the right partner. That's why we created our Capacity Update Partner Week. Watch our video to learn more.

Outsourced Pharma Capacity Update Upcoming Session: April 22, 2025 — Large Molecule Drug Substance & Development

Dive into the biopharmaceutical realm, where the synthesis of biologically derived APIs encompasses cell line development, fermentation, and sophisticated purification techniques. The event will feature insights into process optimization and scale-up, which are crucial for meeting production demands without compromising quality. Register Now.

Upcoming Session: April 22, 2025 (afternoon) — Analytical Services

Gain valuable insights into method validation, biomarker strategies, and tailored analytical solutions for complex modalities. Whether you're focused on large molecules or emerging therapeutics, this session offers critical knowledge to advance your programs. Register now to stay ahead in this dynamic field. Register here.

PAST LARGE MOLECULE DRUG SUBSTANCE & DEVELOPMENT PRESENTATIONS

Northway Biotech Capacity Update January 2025: Large Molecule Development

Over the past 20 years, we have completed more than 175 successful projects around the globe, showcasing our commitment to quality and customer satisfaction.

Request Information

Catalent Capacity Update January 2025: Large Molecule Development

Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

Request Information

Curia Capacity Update October 2024: Large Molecule Drug Substance

We offer adaptable, comprehensive solutions to advance your program seamlessly from IND-enabling studies through to late-stage commercial production.

Request Information

Cytovance Biologics Capacity Update January 2025: Large Molecule Development

Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.

Request Information

EVENT REGISTRATION

Join the OPCU — Large Molecule Drug Substance & Development on Tuesday, April 22, 2025, to explore top CDMOs, compare capabilities, and find the right partners for your project.

 

Register For Free, Here!